Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Obesity (Silver Spring, Md.)
|
September 3, 2017
Effects of Moxonidine and Low-Calorie Diet: Cardiometabolic Benefits from Combination of Both Therapies
Elisabeth A Lambert, Carolina I Sari, Nina Eikelis, et al.
Stress (Amsterdam, Netherlands)
|
July 7, 2007
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor
Murray Esler, Elisabeth Lambert, Marlies Alvarenga, et al.
Journal of Cardiac Failure
|
June 25, 2017
Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study
Ingrid Hopper, Edoardo Gronda, Uta C Hoppe, et al.
Heart Rhythm
|
February 2, 2015
Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering
Alex J A McLellan, Markus P Schlaich, Andrew J Taylor, et al.
Physiological Measurement
|
November 3, 2023
The degree of engagement of cardiac and sympathetic arms of the baroreflex does not depend on the absolute value and sign of arterial pressure variations
Beatrice De Maria, Laura Adelaide Dalla Vecchia, Vlasta Bari, et al.
Circulation
|
June 20, 2013
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension
Felix Mahfoud, Christian Ukena, Roland E Schmieder, et al.
Clinical Cardiology
|
May 11, 2012
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial
David E Kandzari, Deepak L Bhatt, Paul A Sobotka, et al.
Circulation
|
May 21, 2014
Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension"
Felix Mahfoud, Christian Ukena, Roland E Schmieder, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 28, 2005
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia
Philip W Gold, Ma-Li Wong, David S Goldstein, et al.
The Journal of Physiology
|
April 27, 2016
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics
Kalyanam Shivkumar, Olujimi A Ajijola, Inder Anand, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Obesity (Silver Spring, Md.)
|
September 3, 2017
Effects of Moxonidine and Low-Calorie Diet: Cardiometabolic Benefits from Combination of Both Therapies
Elisabeth A Lambert, Carolina I Sari, Nina Eikelis, et al.
Stress (Amsterdam, Netherlands)
|
July 7, 2007
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor
Murray Esler, Elisabeth Lambert, Marlies Alvarenga, et al.
Journal of Cardiac Failure
|
June 25, 2017
Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study
Ingrid Hopper, Edoardo Gronda, Uta C Hoppe, et al.
Heart Rhythm
|
February 2, 2015
Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering
Alex J A McLellan, Markus P Schlaich, Andrew J Taylor, et al.
Physiological Measurement
|
November 3, 2023
The degree of engagement of cardiac and sympathetic arms of the baroreflex does not depend on the absolute value and sign of arterial pressure variations
Beatrice De Maria, Laura Adelaide Dalla Vecchia, Vlasta Bari, et al.
Circulation
|
June 20, 2013
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension
Felix Mahfoud, Christian Ukena, Roland E Schmieder, et al.
Clinical Cardiology
|
May 11, 2012
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial
David E Kandzari, Deepak L Bhatt, Paul A Sobotka, et al.
Circulation
|
May 21, 2014
Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension"
Felix Mahfoud, Christian Ukena, Roland E Schmieder, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 28, 2005
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia
Philip W Gold, Ma-Li Wong, David S Goldstein, et al.
The Journal of Physiology
|
April 27, 2016
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics
Kalyanam Shivkumar, Olujimi A Ajijola, Inder Anand, et al.
Page
of 14